Table:
begin	end	state
1	22	cytoplasmic
23	41	transmembrane
42	60	non-cytoplasmic
61	80	transmembrane
81	91	cytoplasmic
92	112	transmembrane
113	117	non-cytoplasmic
118	141	transmembrane
142	152	cytoplasmic
153	174	transmembrane
175	185	non-cytoplasmic
186	208	transmembrane
209	250	cytoplasmic
251	272	transmembrane
273	286	non-cytoplasmic
287	307	transmembrane
308	317	cytoplasmic
318	336	transmembrane
337	341	non-cytoplasmic
342	362	transmembrane
363	368	cytoplasmic
369	395	transmembrane
396	409	non-cytoplasmic
410	429	transmembrane
430	434	cytoplasmic


Input:
>RR42_RS04270
MTTTAVHSGAADPAFEDATYRKVTLRLVPFLLLCYVVAYLDRVNVGFAKLQMLGDLKFSE
TIYGLGAGIFFIGYFLFEVPSNVILHKVGARIWIARIMITWGVISAAMMFVTTPTMFYVL
RFLLGIAEAGFFPGIILYLTYWYPSHRRGRTTTFFMTAIALSGVIGGPLSGWMMQSFDGR
NGWSGWQWMFLLEGIPSVLVGLVVLAYLDDRIVHAKWLSNEEKALLQRNIAAEDMHKEDA
PIGKVLSSPRVWLMSAIYFSFVMGLYGVSFWLPTIIKQTGVKSPLDIGLLTAIPYGCAVA
GMVLVAYSADRTRERRWHIAIPALLGAVGLVLSVQWHNNTVLALLGLTLATIGILTTLPL
FWSLPTAFLAGTGAAAGIALINSLGNLAGFISPYAVGWLKDMTQSTDSGMYLLAACLVAG
AALTVSVPARMVNK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server